16 Rue Clément Ader Charleroi, Wallonie, 6041 BelgiumIntroduction IQVIA Laboratories Discovery Sciences team provides comprehensive drug discovery solutions. Our suite of specialized, fit-for-purpose labs deliver expertise in antibody discovery and engineering, immunogenicity assessment packages, and protein sciences. Our senior scientists are recognized leaders in their fields and provide thoughtful engagement from initiation through execution. Our integrated lead identification and in vitro/in silico optimization workflows enable faster decision-making, allowing you to begin IND-enabling studies sooner and with more confidence. Antibody Engineering Specifica Biosciences is our antibody engineering lab in Santa Fe, New Mexico. Specifica provides antibody discovery campaigns, exclusive transfers of our library platform, and affinity maturation and developability optimization services. We have built more than 200 naïve sub-libraries, using next-generation sequencing (NGS) at each step of construction and validation to ensure maximum diversity and quality. We use a unique donor set for each library build, ensuring your library is exclusive to you and potentially eliminating future patent concerns. Co-founded by Andrew Bradbury, MB BS, PhD in 2016, our Specifica team brings trusted scientific expertise and numerous published papers in peer-reviewed journals over the past 5 years. Antibodies generated from our libraries using the combination of phage and yeast display have high affinities (60% of antibodies below 10nM; 20% in the sub-nanomolar range; >75% of campaigns, except pMHC, yield at least one subnanomolar antibody), few developability issues (over 80% of antibodies have no biophysical liabilities), and high diversity (10-1000 clusters, depending upon the target), reducing the need for additional optimization. Immunogenicity Our In Vitro Immunology lab in Gosselies, Belgium (formerly ImmunXperts) provides trusted immunogenicity risk assessment services, including in vitro methods with T-cell proliferation as surrogate to measure the immunogenic potential for drug candidates, in silico methods for rapid, low-cost assessment of large number of lead candidates, and MHC-associated peptide proteomics (MAPPS). Cofounded by Sofie Pattyn, our team also performs functional screening assays for immuno-oncology candidates and risk assessment and mitigation of drug candidates’ immunogenicity profiles. Protein Sciences Our Protein Sciences team –in our Laval, Canada lab (previously Nexelis) – brings a decade of expertise in providing recombinant proteins tailored to each customer’s specifications in scale, purity, activity, and other analytical characteristics. We can provide product-specific purification strategies and expression optimization services. Orthogonal evaluation of key parameters—such as size in solution, folding, and sequency integrity—ensures quality and consistency. Our team is experienced in consistently delivering proper characterization to mitigate risk.
i-Tech Incubator 2 Rue Auguste Piccard 48 6041 GosseliesIntroduction IQVIA Laboratories Discovery Sciences team provides comprehensive drug discovery solutions. Our suite of specialized, fit-for-purpose labs deliver expertise in antibody discovery and engineering, immunogenicity assessment packages, and protein sciences. Our senior scientists are recognized leaders in their fields and provide thoughtful engagement from initiation through execution. Our integrated lead identification and in vitro/in silico optimization workflows enable faster decision-making, allowing you to begin IND-enabling studies sooner and with more confidence. Antibody Engineering Specifica Biosciences is our antibody engineering lab in Santa Fe, New Mexico. Specifica provides antibody discovery campaigns, exclusive transfers of our library platform, and affinity maturation and developability optimization services. We have built more than 200 naïve sub-libraries, using next-generation sequencing (NGS) at each step of construction and validation to ensure maximum diversity and quality. We use a unique donor set for each library build, ensuring your library is exclusive to you and potentially eliminating future patent concerns. Co-founded by Andrew Bradbury, MB BS, PhD in 2016, our Specifica team brings trusted scientific expertise and numerous published papers in peer-reviewed journals over the past 5 years. Antibodies generated from our libraries using the combination of phage and yeast display have high affinities (60% of antibodies below 10nM; 20% in the sub-nanomolar range; >75% of campaigns, except pMHC, yield at least one subnanomolar antibody), few developability issues (over 80% of antibodies have no biophysical liabilities), and high diversity (10-1000 clusters, depending upon the target), reducing the need for additional optimization. Immunogenicity Our In Vitro Immunology lab in Gosselies, Belgium (formerly ImmunXperts) provides trusted immunogenicity risk assessment services, including in vitro methods with T-cell proliferation as surrogate to measure the immunogenic potential for drug candidates, in silico methods for rapid, low-cost assessment of large number of lead candidates, and MHC-associated peptide proteomics (MAPPS). Cofounded by Sofie Pattyn, our team also performs functional screening assays for immuno-oncology candidates and risk assessment and mitigation of drug candidates’ immunogenicity profiles. Protein Sciences Our Protein Sciences team –in our Laval, Canada lab (previously Nexelis) – brings a decade of expertise in providing recombinant proteins tailored to each customer’s specifications in scale, purity, activity, and other analytical characteristics. We can provide product-specific purification strategies and expression optimization services. Orthogonal evaluation of key parameters—such as size in solution, folding, and sequency integrity—ensures quality and consistency. Our team is experienced in consistently delivering proper characterization to mitigate risk.
1607 Alcaldesa St Santa Fe, NM, 87501 3070 United StatesIntroduction IQVIA Laboratories Discovery Sciences team provides comprehensive drug discovery solutions. Our suite of specialized, fit-for-purpose labs deliver expertise in antibody discovery and engineering, immunogenicity assessment packages, and protein sciences. Our senior scientists are recognized leaders in their fields and provide thoughtful engagement from initiation through execution. Our integrated lead identification and in vitro/in silico optimization workflows enable faster decision-making, allowing you to begin IND-enabling studies sooner and with more confidence. Antibody Engineering Specifica Biosciences is our antibody engineering lab in Santa Fe, New Mexico. Specifica provides antibody discovery campaigns, exclusive transfers of our library platform, and affinity maturation and developability optimization services. We have built more than 200 naïve sub-libraries, using next-generation sequencing (NGS) at each step of construction and validation to ensure maximum diversity and quality. We use a unique donor set for each library build, ensuring your library is exclusive to you and potentially eliminating future patent concerns. Co-founded by Andrew Bradbury, MB BS, PhD in 2016, our Specifica team brings trusted scientific expertise and numerous published papers in peer-reviewed journals over the past 5 years. Antibodies generated from our libraries using the combination of phage and yeast display have high affinities (60% of antibodies below 10nM; 20% in the sub-nanomolar range; >75% of campaigns, except pMHC, yield at least one subnanomolar antibody), few developability issues (over 80% of antibodies have no biophysical liabilities), and high diversity (10-1000 clusters, depending upon the target), reducing the need for additional optimization. Immunogenicity Our In Vitro Immunology lab in Gosselies, Belgium (formerly ImmunXperts) provides trusted immunogenicity risk assessment services, including in vitro methods with T-cell proliferation as surrogate to measure the immunogenic potential for drug candidates, in silico methods for rapid, low-cost assessment of large number of lead candidates, and MHC-associated peptide proteomics (MAPPS). Cofounded by Sofie Pattyn, our team also performs functional screening assays for immuno-oncology candidates and risk assessment and mitigation of drug candidates’ immunogenicity profiles. Protein Sciences Our Protein Sciences team –in our Laval, Canada lab (previously Nexelis) – brings a decade of expertise in providing recombinant proteins tailored to each customer’s specifications in scale, purity, activity, and other analytical characteristics. We can provide product-specific purification strategies and expression optimization services. Orthogonal evaluation of key parameters—such as size in solution, folding, and sequency integrity—ensures quality and consistency. Our team is experienced in consistently delivering proper characterization to mitigate risk.
275 Boul Armand Frappier Laval, Québec, H7V 4A7 CanadaIntroduction IQVIA Laboratories Discovery Sciences team provides comprehensive drug discovery solutions. Our suite of specialized, fit-for-purpose labs deliver expertise in antibody discovery and engineering, immunogenicity assessment packages, and protein sciences. Our senior scientists are recognized leaders in their fields and provide thoughtful engagement from initiation through execution. Our integrated lead identification and in vitro/in silico optimization workflows enable faster decision-making, allowing you to begin IND-enabling studies sooner and with more confidence. Antibody Engineering Specifica Biosciences is our antibody engineering lab in Santa Fe, New Mexico. Specifica provides antibody discovery campaigns, exclusive transfers of our library platform, and affinity maturation and developability optimization services. We have built more than 200 naïve sub-libraries, using next-generation sequencing (NGS) at each step of construction and validation to ensure maximum diversity and quality. We use a unique donor set for each library build, ensuring your library is exclusive to you and potentially eliminating future patent concerns. Co-founded by Andrew Bradbury, MB BS, PhD in 2016, our Specifica team brings trusted scientific expertise and numerous published papers in peer-reviewed journals over the past 5 years. Antibodies generated from our libraries using the combination of phage and yeast display have high affinities (60% of antibodies below 10nM; 20% in the sub-nanomolar range; >75% of campaigns, except pMHC, yield at least one subnanomolar antibody), few developability issues (over 80% of antibodies have no biophysical liabilities), and high diversity (10-1000 clusters, depending upon the target), reducing the need for additional optimization. Immunogenicity Our In Vitro Immunology lab in Gosselies, Belgium (formerly ImmunXperts) provides trusted immunogenicity risk assessment services, including in vitro methods with T-cell proliferation as surrogate to measure the immunogenic potential for drug candidates, in silico methods for rapid, low-cost assessment of large number of lead candidates, and MHC-associated peptide proteomics (MAPPS). Cofounded by Sofie Pattyn, our team also performs functional screening assays for immuno-oncology candidates and risk assessment and mitigation of drug candidates’ immunogenicity profiles. Protein Sciences Our Protein Sciences team –in our Laval, Canada lab (previously Nexelis) – brings a decade of expertise in providing recombinant proteins tailored to each customer’s specifications in scale, purity, activity, and other analytical characteristics. We can provide product-specific purification strategies and expression optimization services. Orthogonal evaluation of key parameters—such as size in solution, folding, and sequency integrity—ensures quality and consistency. Our team is experienced in consistently delivering proper characterization to mitigate risk.
Rue Clément Ader 10 Gosselies, 6041 BelgiumIntroduction IQVIA Laboratories Discovery Sciences team provides comprehensive drug discovery solutions. Our suite of specialized, fit-for-purpose labs deliver expertise in antibody discovery and engineering, immunogenicity assessment packages, and protein sciences. Our senior scientists are recognized leaders in their fields and provide thoughtful engagement from initiation through execution. Our integrated lead identification and in vitro/in silico optimization workflows enable faster decision-making, allowing you to begin IND-enabling studies sooner and with more confidence. Antibody Engineering Specifica Biosciences is our antibody engineering lab in Santa Fe, New Mexico. Specifica provides antibody discovery campaigns, exclusive transfers of our library platform, and affinity maturation and developability optimization services. We have built more than 200 naïve sub-libraries, using next-generation sequencing (NGS) at each step of construction and validation to ensure maximum diversity and quality. We use a unique donor set for each library build, ensuring your library is exclusive to you and potentially eliminating future patent concerns. Co-founded by Andrew Bradbury, MB BS, PhD in 2016, our Specifica team brings trusted scientific expertise and numerous published papers in peer-reviewed journals over the past 5 years. Antibodies generated from our libraries using the combination of phage and yeast display have high affinities (60% of antibodies below 10nM; 20% in the sub-nanomolar range; >75% of campaigns, except pMHC, yield at least one subnanomolar antibody), few developability issues (over 80% of antibodies have no biophysical liabilities), and high diversity (10-1000 clusters, depending upon the target), reducing the need for additional optimization. Immunogenicity Our In Vitro Immunology lab in Gosselies, Belgium (formerly ImmunXperts) provides trusted immunogenicity risk assessment services, including in vitro methods with T-cell proliferation as surrogate to measure the immunogenic potential for drug candidates, in silico methods for rapid, low-cost assessment of large number of lead candidates, and MHC-associated peptide proteomics (MAPPS). Cofounded by Sofie Pattyn, our team also performs functional screening assays for immuno-oncology candidates and risk assessment and mitigation of drug candidates’ immunogenicity profiles. Protein Sciences Our Protein Sciences team –in our Laval, Canada lab (previously Nexelis) – brings a decade of expertise in providing recombinant proteins tailored to each customer’s specifications in scale, purity, activity, and other analytical characteristics. We can provide product-specific purification strategies and expression optimization services. Orthogonal evaluation of key parameters—such as size in solution, folding, and sequency integrity—ensures quality and consistency. Our team is experienced in consistently delivering proper characterization to mitigate risk.
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.